[Accessed on 11 June 2026] Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial (2023)
If symptoms are severe, your doctor may delay dose escalation, reduce the dose, or review whether the medicine is suitable for you
This trajectory signals more than a clinical challenge
Weight loss can negatively impact muscle mass, which is why our goal at LIVation is to have you lose half a pound to two pounds per week to help preserve lean muscle
Unlike bariatric surgery, medical weight loss programs focus on customized plans that include nutrition counseling, lifestyle coaching, and medications to support safe and sustainable results